
Bruck Kifle
Examiner (ID: 2332)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 1624, 1611, 1622 |
| Total Applications | 3434 |
| Issued Applications | 2601 |
| Pending Applications | 222 |
| Abandoned Applications | 651 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7020102
[patent_doc_number] => 20050222121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Atypical antipsychotic agents having low affinity for the D2 receptor'
[patent_app_type] => utility
[patent_app_number] => 11/031352
[patent_app_country] => US
[patent_app_date] => 2005-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15123
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222121.pdf
[firstpage_image] =>[orig_patent_app_number] => 11031352
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/031352 | Atypical antipsychotic agents having low affinity for the D2 receptor | Jan 9, 2005 | Abandoned |
Array
(
[id] => 6983866
[patent_doc_number] => 20050153936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders'
[patent_app_type] => utility
[patent_app_number] => 11/030043
[patent_app_country] => US
[patent_app_date] => 2005-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2617
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153936.pdf
[firstpage_image] =>[orig_patent_app_number] => 11030043
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/030043 | Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders | Jan 6, 2005 | Issued |
Array
(
[id] => 806744
[patent_doc_number] => 07419979
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-02
[patent_title] => 'Derivatives of 6-{4-[4-(1H-indole-2-sulphonyl)-piperazin-1-carbonyl-phenyl]}pyradizin-3-one'
[patent_app_type] => utility
[patent_app_number] => 10/584473
[patent_app_country] => US
[patent_app_date] => 2005-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8904
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/419/07419979.pdf
[firstpage_image] =>[orig_patent_app_number] => 10584473
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/584473 | Derivatives of 6-{4-[4-(1H-indole-2-sulphonyl)-piperazin-1-carbonyl-phenyl]}pyradizin-3-one | Jan 4, 2005 | Issued |
Array
(
[id] => 7597601
[patent_doc_number] => 07618976
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-17
[patent_title] => 'Methods for the production of sildenafil base and citrate salt'
[patent_app_type] => utility
[patent_app_number] => 11/030545
[patent_app_country] => US
[patent_app_date] => 2005-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5314
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/618/07618976.pdf
[firstpage_image] =>[orig_patent_app_number] => 11030545
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/030545 | Methods for the production of sildenafil base and citrate salt | Jan 4, 2005 | Issued |
Array
(
[id] => 5515436
[patent_doc_number] => 20090215743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Tricyclic benzazepine derivatives and their use'
[patent_app_type] => utility
[patent_app_number] => 10/586023
[patent_app_country] => US
[patent_app_date] => 2004-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28730
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215743.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586023
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586023 | Tricyclic benzazepine derivatives and their use | Dec 30, 2004 | Abandoned |
Array
(
[id] => 6939800
[patent_doc_number] => 20050113363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Hydroxyalkanoylaminolactams and related structures as inhibitors of A beta protein production'
[patent_app_type] => utility
[patent_app_number] => 11/024377
[patent_app_country] => US
[patent_app_date] => 2004-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46779
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113363.pdf
[firstpage_image] =>[orig_patent_app_number] => 11024377
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/024377 | Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production | Dec 27, 2004 | Issued |
Array
(
[id] => 535360
[patent_doc_number] => 07173026
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-06
[patent_title] => 'Pyrrolo [2,1-c][1,4]benzodiazepine-anthraquinone conjugates useful as antitumour agents'
[patent_app_type] => utility
[patent_app_number] => 11/024240
[patent_app_country] => US
[patent_app_date] => 2004-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3282
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/173/07173026.pdf
[firstpage_image] =>[orig_patent_app_number] => 11024240
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/024240 | Pyrrolo [2,1-c][1,4]benzodiazepine-anthraquinone conjugates useful as antitumour agents | Dec 26, 2004 | Issued |
Array
(
[id] => 5904881
[patent_doc_number] => 20060047113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-02
[patent_title] => 'Metal oxide-containing kenyaite catalyst, method for preparing the same, and method for preparing epsilon-caprolactam using the same'
[patent_app_type] => utility
[patent_app_number] => 11/022250
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4264
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20060047113.pdf
[firstpage_image] =>[orig_patent_app_number] => 11022250
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/022250 | Metal oxide-containing kenyaite catalyst, method for preparing the same, and method for preparing ε-caprolactam using the same | Dec 22, 2004 | Issued |
Array
(
[id] => 7105435
[patent_doc_number] => 20050107418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Macrolides'
[patent_app_type] => utility
[patent_app_number] => 11/020860
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2700
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107418.pdf
[firstpage_image] =>[orig_patent_app_number] => 11020860
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/020860 | Macrolides | Dec 22, 2004 | Issued |
Array
(
[id] => 411691
[patent_doc_number] => 07282493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-16
[patent_title] => 'Analogs of benzoquinone-containing ansamycins and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/022057
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 70
[patent_figures_cnt] => 70
[patent_no_of_words] => 38690
[patent_no_of_claims] => 146
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/282/07282493.pdf
[firstpage_image] =>[orig_patent_app_number] => 11022057
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/022057 | Analogs of benzoquinone-containing ansamycins and methods of use thereof | Dec 22, 2004 | Issued |
Array
(
[id] => 750064
[patent_doc_number] => 07022690
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-04
[patent_title] => 'Carboxylic acid substituted heterocycles, derivatives thereof and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/020751
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20454
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/022/07022690.pdf
[firstpage_image] =>[orig_patent_app_number] => 11020751
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/020751 | Carboxylic acid substituted heterocycles, derivatives thereof and methods of use | Dec 22, 2004 | Issued |
Array
(
[id] => 817155
[patent_doc_number] => 07410963
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-12
[patent_title] => 'Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/582131
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 31833
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/410/07410963.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582131
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582131 | Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof | Dec 22, 2004 | Issued |
Array
(
[id] => 425183
[patent_doc_number] => 07271165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-18
[patent_title] => 'Rifamycin analogs and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/020870
[patent_app_country] => US
[patent_app_date] => 2004-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32582
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/271/07271165.pdf
[firstpage_image] =>[orig_patent_app_number] => 11020870
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/020870 | Rifamycin analogs and uses thereof | Dec 21, 2004 | Issued |
Array
(
[id] => 4977949
[patent_doc_number] => 20070219182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Keto Lactam Compounds and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/582285
[patent_app_country] => US
[patent_app_date] => 2004-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35026
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20070219182.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582285
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582285 | Keto lactam compounds and use thereof | Dec 9, 2004 | Issued |
Array
(
[id] => 6997411
[patent_doc_number] => 20050137189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Rifamycin analogs and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/008597
[patent_app_country] => US
[patent_app_date] => 2004-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16364
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20050137189.pdf
[firstpage_image] =>[orig_patent_app_number] => 11008597
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/008597 | Rifamycin analogs and uses thereof | Dec 8, 2004 | Issued |
Array
(
[id] => 5890028
[patent_doc_number] => 20060276478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Pyrazolopyrimidines'
[patent_app_type] => utility
[patent_app_number] => 10/581775
[patent_app_country] => US
[patent_app_date] => 2004-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12813
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276478.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581775
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581775 | Pyrazolopyrimidines | Dec 7, 2004 | Abandoned |
Array
(
[id] => 5113624
[patent_doc_number] => 20070197540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Pyrazolopyrimidines'
[patent_app_type] => utility
[patent_app_number] => 10/581776
[patent_app_country] => US
[patent_app_date] => 2004-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15674
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20070197540.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581776
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581776 | Pyrazolopyrimidines | Dec 7, 2004 | Abandoned |
Array
(
[id] => 7200376
[patent_doc_number] => 20050165002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Process for the manufacture of a product of the thiazolo [3,4,5-de] [4,1]benzothiazepine type'
[patent_app_type] => utility
[patent_app_number] => 11/005224
[patent_app_country] => US
[patent_app_date] => 2004-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6949
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20050165002.pdf
[firstpage_image] =>[orig_patent_app_number] => 11005224
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/005224 | Process for the manufacture of a product of the thiazolo [3,4,5-de] [4,1]benzothiazepine type | Dec 5, 2004 | Issued |
Array
(
[id] => 418823
[patent_doc_number] => 07276495
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-02
[patent_title] => 'Substituted lactams as inhibitors of Aβ protein production'
[patent_app_type] => utility
[patent_app_number] => 11/005573
[patent_app_country] => US
[patent_app_date] => 2004-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35160
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/276/07276495.pdf
[firstpage_image] =>[orig_patent_app_number] => 11005573
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/005573 | Substituted lactams as inhibitors of Aβ protein production | Dec 5, 2004 | Issued |
Array
(
[id] => 7188051
[patent_doc_number] => 20050192269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds'
[patent_app_type] => utility
[patent_app_number] => 11/002951
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 99296
[patent_no_of_claims] => 123
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20050192269.pdf
[firstpage_image] =>[orig_patent_app_number] => 11002951
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/002951 | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds | Dec 2, 2004 | Abandoned |